# Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects

> **NCT01355354** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 21 (estimated)

## Conditions studied

- Healthy Volunteers
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Fostamatinib

## Key facts

- **NCT ID:** NCT01355354
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2011-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355354, "Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01355354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*